DFine, maker of an injection device that heals vertebral fractures, has raised $36.2 million in equity. Prospect Venture Partners, BB&T Fund, Split Rock Partners and OrbiMed Advisors participated in the round, according to a filing with the SEC. The San Jose-based company uses a minimally invasive procedure to treat spine fractures, providing patients with immediate pain relief and a fast recovery.
Founded in 2004, DFine previously raised more than $60 million.
